Want to see GB:EMVC full AI Analyst Report?
NetScientific (EMVC) AI Stock Analysis
NetScientific
(LSE:EMVC)
Financial performance weighs most heavily due to revenue gains offset by ongoing losses and cash burn. Technical momentum offers moderate support while weak valuation from negative earnings caps the overall score.
NetScientific (EMVC) vs. iShares MSCI United Kingdom ETF (EWC)
- Market Cap
- GBP 11.75M
- Dividend Yield
- ―
- Average Volume (3M)
- 21.01K
- Price to Earnings (P/E)
- 0.6
- Beta (1Y)
- 0.71
- Revenue Growth
- 31.28%
- EPS Growth
- ―
- Country
- UK
- Employees
- 21
- Sector
- Financial
- Sector Strength
- 68
- Industry
- Asset Management
NetScientific Business Overview & Revenue Model
Company Description
EMV Capital plc operates as a venture capital firm, primarily targeting investments across the full spectrum of early-stage funding, from seed rounds through to mid-stage and growth capital. Its investment mandate spans diverse high-growth sectors, i...
How the Company Makes Money
NetScientific generally makes money through value creation in its portfolio companies rather than through sales of a single operating product. Its primary economic model is (i) equity ownership in portfolio companies and (ii) realizing gains when tho...
NetScientific Financial Statement Overview
Summary
Solid revenue growth and high gross margins offset by persistent net losses and negative cash flows, with low debt levels providing some balance sheet stability.
Income Statement
45NeutralBalance Sheet
55NeutralCash Flow
40Negative| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 3.10M | 2.87M | 2.45M | 1.45M | 1.00M | 1.11M |
| Gross Profit | 2.38M | 2.25M | 2.09M | 1.23M | 782.00K | 989.00K |
| EBITDA | -1.54M | -1.52M | -3.12M | -2.27M | -3.31M | -2.65M |
| Net Income | 19.25M | -21.00K | -3.06M | -2.64M | -3.09M | -2.38M |
Balance Sheet | ||||||
| Total Assets | 41.67M | 19.78M | 19.50M | 22.46M | 28.95M | 20.69M |
| Cash, Cash Equivalents and Short-Term Investments | 656.00K | 511.00K | 949.00K | 347.00K | 580.00K | 2.35M |
| Total Debt | 810.00K | 2.60M | 1.53M | 2.53M | 1.25M | 654.00K |
| Total Liabilities | 8.23M | 6.13M | 5.43M | 5.35M | 3.71M | 2.18M |
| Stockholders Equity | 33.32M | 15.21M | 15.10M | 17.83M | 25.84M | 18.50M |
Cash Flow | ||||||
| Free Cash Flow | -1.47M | -1.27M | -1.97M | -3.51M | -3.16M | -3.54M |
| Operating Cash Flow | -1.45M | -1.24M | -1.78M | -3.14M | -2.56M | -3.48M |
| Investing Cash Flow | 280.00K | 279.00K | 12.00K | 1.11M | -1.08M | -3.46M |
| Financing Cash Flow | 1.28M | 477.00K | 2.57M | 1.39M | 1.74M | 8.02M |
NetScientific Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For GB:EMVC, the sentiment is Negative. The current price of 41.98 is below the 20-day moving average (MA) of 44.23, below the 50-day MA of 46.33, and below the 200-day MA of 50.70, indicating a bearish trend. The MACD of -1.33 indicates Positive momentum. The RSI at 31.47 is Neutral, neither overbought nor oversold. The STOCH value of 26.19 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for GB:EMVC.
NetScientific Peers Comparison
Overall Rating
GB:MAFL62Neutral- GB:EMVC51Neutral
GB:FIPP43Neutral
GB:TEAM42Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| Sector * | 68Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% |
| GB:MAFL | 62Neutral | GBP 15.19M | 4.17 | 23.41% | ― | 543.02% | 30.22% |
| GB:EMVC | 51Neutral | GBP 11.75M | 0.61 | 79.34% | ― | 31.28% | ― |
| GB:FIPP | 43Neutral | GBP 12.67M | -0.99 | -19.23% | ― | 7.43% | -51.54% |
| GB:TEAM | 42Neutral | GBP 18.23M | -2.79 | -25.29% | ― | 8.61% | 39.01% |
* Financial Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| GB:EMVC | NetScientific plc | 42.00 | -4.00 | -8.70% | |
| GB:FIPP | Frontier IP | 11.25 | -12.75 | -53.13% | |
| GB:MAFL | Mineral & Financial Investments | 39.00 | 6.00 | 18.18% | |
| GB:TEAM | TEAM plc | 14.75 | -11.25 | -43.27% |
NetScientific Corporate Events
Glycotest secures key MUSC biomarker licence to bolster liver fibrosis diagnostics
PositiveEMV Capital’s portfolio company Glycotest has secured an exclusive worldwide licence from the Zucker Institute for Innovation Commercialization at the Medical University of South Carolina for intellectual property underpinning its blood test to...
EMV Capital lifts NAV as portfolio matures and platform scales
PositiveEMV Capital reported interim results showing net assets rising to £33.4 million and NAV per share up 145% to £1.20, driven largely by the deconsolidation of diagnostics firms Glycotest and ProAxsis, with Adjusted NAV per share up 16% on an...
EMV Capital Sets Date for Interim Results and Investor Presentation
PositiveEMV Capital plc will publish its interim results for the six months to 30 June 2026 on 24 September 2026 and host a live online presentation for analysts and investors later that day via the Investor Meet Company platform. The event, open to existing...
EMV Capital Acquires Rotterdam Plastics Recycling Plant for Venture Build Expansion
PositiveEMV Capital has acquired the Pryme One industrial-scale plastic waste chemical recycling plant in Rotterdam through its newly formed wholly owned subsidiary Winalot BV, in a debt-funded deal that includes associated assets and intellectual property....
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Aug 20, 2026